HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 4, 2397-2406, January 25, 2008

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 283/4/2397    most recent M708169200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chutkow, W. A. Articles by Lee, R. T. Search for Related Content PubMed PubMed Citation Articles by Chutkow, W. A. Articles by Lee, R. T. Social Bookmarking                      What's this?

Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production^*

From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Cambridge, Massachusetts 02139

Thioredoxin-interacting protein (Txnip) has been recently described as a possible link between cellular redox state and metabolism; Txnip binds thioredoxin and inhibits its disulfide reductase activity in vitro, while a naturally occurring strain of Txnip-deficient mice has hyperlipidemia, hypoglycemia, and ketosis exacerbated by fasting. We generated Txnip-null mice to investigate the role of Txnip in glucose homeostasis. Txnip-null mice were hypoglycemic, hypoinsulinemic, and had blunted glucose production following a glucagon challenge, consistent with a central liver glucose-handling defect. Glucose release from isolated Txnip-null hepatocytes was 2-fold lower than wild-type hepatocytes, whereas β-hydroxybutyrate release was increased 2-fold, supporting an intrinsic defect in hepatocyte glucose metabolism. While hepatocyte-specific gene deletion of Txnip did not alter glucose clearance compared with littermate controls, Txnip expression in the liver was required for maintaining normal fasting glycemia and glucose production. In addition, hepatic overexpression of a Txnip transgene in wild-type mice resulted in elevated serum glucose levels and decreased ketone levels. Liver homogenates from Txnip-null mice had no significant differences in the glutathione oxidation state or in the amount of available thioredoxin. However, overexpression of wild-type Txnip in Txnip-null hepatocytes rescued cellular glucose production, whereas overexpression of a C247S mutant Txnip, which does not bind thioredoxin, had no effect. These data demonstrate that Txnip is required for normal glucose homeostasis in the liver. While available thioredoxin is not changed in Txnip-null mice, the effects of Txnip on glucose homeostasis are abolished by a single cysteine mutation that inhibits binding to thioredoxin.

Received for publication, October 2, 2007

^* This work was supported by National Institutes of Health Grants HL073809 and HL048743 (to R. T. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental "Methods," Figs. S1-S4, and references.

¹ Both authors contributed equally to this work.

² To whom correspondence should be addressed: Partners Research Facility, 65 Landsdowne St., Rm. 280, Cambridge, MA 02139. Tel.: 617-768-8282; E-mail: wchutkow{at}partners.org.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F.-X. Yu, S.-R. Goh, R.-P. Dai, and Y. Luo Adenosine-Containing Molecules Amplify Glucose Signaling and Enhance Txnip Expression Mol. Endocrinol., June 1, 2009; 23(6): 932 - 942. [Abstract] [Full Text] [PDF]

				J. Chen, S. T. Hui, F. M. Couto, I. N. Mungrue, D. B. Davis, A. D. Attie, A. J. Lusis, R. A. Davis, and A. Shalev Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes FASEB J, October 1, 2008; 22(10): 3581 - 3594. [Abstract] [Full Text] [PDF]

				J. Chen, G. Saxena, I. N. Mungrue, A. J. Lusis, and A. Shalev Thioredoxin-Interacting Protein: A Critical Link Between Glucose Toxicity and {beta}-Cell Apoptosis Diabetes, April 1, 2008; 57(4): 938 - 944. [Abstract] [Full Text] [PDF]